Genetic determinants of survival in patients with Alzheimer's disease
Manuscript Number:
14-2442R1
Author(s):
Mahmud M. Barmada, James T. Becker, Steven T. DeKosky, F. Yesim Demirci, Eleanor Feingold, M. Ilyas Kamboh, Oscar Lopez, Robert A. Sweet, Xingbin Wang
Disclosures
Mahmud M. Barmada
Lecture Fees:
Travel/lodging for presentations at Cophenagenomics 2013 (July, 2013) and the European Society of Human Genetics (ESHG) meeting (also July, 2013) - support provided by CLCbio (now Qiagen)
James T. Becker
Nothing to Disclose
Steven T. DeKosky
Consulting Fees:
AztraZeneca (consultant for preclinical development of drugs for dementia)
Merck (consultant for preclinical development of drugs for dementia)
Rivermend (addiction advisory board)
Novartis (consultant for preclinical development of drugs for dementia)